Drug Database
Back to search

Switzerland· 61884001

UROCIT, Tabletten

A urinary concrement solvents product containing kalii citras, registered in Switzerland by RECORDATI AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC G04BC

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedUROCIT, TablettenATCG04BCREGISTER NO.61884001PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about kalii citrasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Kalii citras is registered in 5 of 19 countries.

Countries holding a registration under ATC G04BC (urinary concrement solvents), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 5 of them publish a price we can compare per daily dose
Search kalii citras products by name

Kalii citras · ATC G04BC

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
kalii citras
Manufacturer
RECORDATI AG
Country
Switzerland (CH)
ATC code
G04BC
ATC class
Urinary concrement solvents
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680618840019
    100 Stk
    CHF 61.35

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Kalii citras in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All kalii citras products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Kacital, Kaliumchlorid B. Braun
  • Belgium · Chlorure De Potassium Noridem, Kacital
  • Bulgaria · Калиев Хлорид Браун, Нефромелтар
  • Cyprus · Sopa-K, Καλιο Χλωριουχο Demo
  • Czechia · Ardeaelytosol, Kalium Chloratum Biomedica
  • Germany · 1 M-Kaliumchlorid-Lösung Deltamedica, 1m-Kaliumchlorid-Lösung Fresenius
  • Denmark · Alkacit, Kaleorid
  • Estonia · Potassium Chloride Braun, Potassium Chloride Kabi
  • Spain · Acalka, Acetato De Potasio B.Braun
  • Finland · Addex-Kaliumklorid, Alkacit
  • France · Chlorure De Potassium B. Braun, Chlorure De Potassium Cooper
  • United Kingdom (Northern Ireland) · Cystopurin, Kay-Cee-L
  • Greece · Potassium Chloride Demo Αβεε, Potassium Chloride Noridem
  • Croatia · 1 M Kalijev Klorid Hztm, Kalijev Klorid B. Braun
  • Hungary · Kaldyum, Kalii Citratis Fono Viii. Naturland
  • Ireland · Cystopurin, Kacital
  • Iceland · Alkacit, Kaleorid
  • Italy · Kcl-Retard, Lento-Kalium
  • Lithuania · Potassium Chloride Braun, Potassium Chloride Fresenius
  • Luxembourg · Kalinor-Retard P, Kaliumchlorid Braun
  • Latvia · Potassium Chloride Braun, Potassium Chloride Kabi
  • Malta · Cystopurin, Potassium Chloride Monico
  • Netherlands · Kacital, Kaliumchloride
  • Norway · Addex, Addex Kaliumklorid
  • Poland · Kaldyum, Kalipoz Prolongatum
  • Portugal · Acalka, Cloreto De Potássio Basi
  • Romania · Clorură De Potasiu Braun, Clorură De Potasiu Kabi
  • Sweden · Addens-Kaliumklorid B. Braun, Addex-Kaliumklorid
  • Slovenia · Kalijev Klorid B. Braun, Kalijev Klorid Jadran
  • Slovakia · Kaldyum, Kalium Chloratum Biomedica

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/969bc074-9188-4307-bb33-9d6ee94f2c96
GET /v1/drugs/969bc074-9188-4307-bb33-9d6ee94f2c96?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "kalii citras (e332) (3:1) 1080 mg",
  "valid_from": "2012-11-01",
  "limitations": "[{\"description\":\"Zur Alkalisierung des Harnes bei Patienten mit Nierensteinen in der Anamnese, zur Rezidivprophylaxe.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2014-11-01\"}]",
  "galenic_form": "Tabl",
  "therapeutic_area": null,
  "sl_inclusion_date": "2012-11-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about kalii citras.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console